New York’s marijuana regulators are celebrating the opening of the state’s 500th legal cannabis dispensary, citing $2.3 billion in adult sales since the market opened, supporting about 25,000 jobs across the industry.
At a ribbon-cutting ceremony Friday, Green Comfort Dispensary became the 500th adult-use marijuana licensee to open its doors in the state since its launch in late 2022.
Felicia AB Reid, executive director of the Office of Cannabis Management (OCM), said in a press release that “the growing number of licensed dispensaries reflects a market that is maturing with a purpose.”
“Every new business represents economic growth, community investment and safer access for consumers,” he said. “Together, New York’s legal cannabis market, industry innovation and consumer demand show no signs of slowing down,” they state.
Beyond the 500 store milestone, OCM also highlighted other industry growth statistics, including the approval of 1,949 adult cannabis businesses across all license types. Today there are dispensaries in 51 regions and 161 municipalities throughout the state.
“Each licensed store represents an operator, proven products and a community that chooses safer cannabis,” said Jessica Garcia, president of the Cannabis Control Board (CCB). “Reaching 500 shows the momentum of the industry and our focus on equity, compliance and consumer protection.”
Of the nearly 2,000 adult-use licenses issued so far, OCM said 56 percent have gone to social equity businesses that have been disproportionately affected by the ban.
With tax revenue from marijuana sales and license fees, $5 million has been invested in community reinvestment initiatives, another $5 million has gone toward a grant program for conditional business licenses for eligible applicants, and $2.6 million has contributed to technical assistance for those seeking to enter the market.
“Equity has been the bedrock of this market since the beginning,” said Simone Washington, Chief Equity Officer at OCM. “Achieving this milestone reinforces that progress is possible when equity is built and embedded in the system. Our focus remains that equity is not just a paper principle, but a measurable outcome at every level of the industry.”
Tim Tanavung, CEO of Green Comfort Dispensary, said “it is truly an honor to be recognized as NYS’s 500th licensed historic dispensary.”
“It is truly a labor of love and passion from myself, David and the entire staff at Green Comfort,” he said. “We are excited to promote a vessel that we can give back to the community, the city of Rochester and the state. We are optimistic for the future of Green Comfort and NYS cannabis.”
Meanwhile, given the confusion in the market about temporary license terms, the CCB said it will extend the renewal period for adult conditional use to December 31, 2026.
“This extension provides more time for licensees to secure viable locations and obtain full licensure,” OCM said. “It will also apply to temporary licenses issued between September 9, 2025 and December 30, 2025, ensuring clarity and consistency for all temporary licensees.”
Part of the uncertainty surrounding provisional licensees a the recently identified zoning issue affects more than 100 cannabis businesses Those located too close to public schools or places of worship than permitted by applicable statute. Gov. Kathy Hochul (D) said she will push the legislature to change the state’s marijuana law to address the problem.
If signed into law, the measure would give cannabis manufacturers and distributors an extra 30 days to file their tax returns after the end of each quarterly tax year. Currently, companies have 20 days to submit documents, and the legislation would extend it to 50 days.
Sponsors of the bill noted that Hochul vetoed the cannabis business tax reform proposal late last year, saying it would lead to “significant operational challenges for the state and confusion for taxpayers,” but that they have worked to address those concerns in the current version.
About three months after opening applications Conditional Adult Use Retail Dispensary (CAURD) Grant ProgramOCM and Empire State Development (ESD) announced Wednesday that 52 licensed dispensaries have been awarded up to $30,000 each for start-up and operating costs such as rent, renovations, inventory tracking and security systems.
To enter the program, applicants must be “justice-involved,” meaning a marijuana-related conviction, and experience running a profitable business.
Meanwhile, OCM recently launched a new online map to help adults find licensed marijuana shops—one of the latest efforts to encourage consumers to buy their cannabis on the regulated market.
After a surprising expansion of the state’s legalization law opened the door to a proliferation of illegal marijuana shops, governors and regulators have made it a priority to educate citizens about the need to buy their products from licensed dispensaries as a health and safety imperative.
The broader New York campaign also involved digital advertising and educational resources, including a guide to safe consumption practices, as well as graphics and videos from licensed cannabis business owners and messages about the benefits of participating in the regulated market.
In April, New York cannabis regulators and labor officials has announced the launch of a staff training program The state’s marijuana industry is legally required to “provide comprehensive safety training to employees.”
Additionally, the press secretary of the OCM stated that the office is working on plans to expand permit and license regulations. adults can buy and use marijuana in movie theaters. Allowing the sale of cannabis products in theaters would set New York apart as the state continues to build legalization legislation.
Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.
Those wishing to grow and process hemp this year must apply for a license from the Minnesota Department of Agriculture (MDA) by April 30. Each license is valid until December 31 of the year it is issued. Graduates must reapply annually to continue in the program. An MDA license is required for individuals and businesses.
So far, about 30 people have applied for the 2026 MDA license, compared to 84 applicants last year.
These licenses are for the cultivation and processing of industrial hemp only. The hemp license application is not for adult use or for growing or selling medical cannabis. The application is also not intended for the sale of hemp-derived cannabinoid products. Information on adult use and medical cannabis is available Office of Cannabis Management (OCM) website.
There are applications of industrial hemp MDA website. Along with the online form, first-time applicants and authorized representatives must submit fingerprints and pass a criminal background check.
There are also several updates for the 2026 season. The extraction of cannabinoids from hemp is now regulated by the OCM, meaning that anyone interested in this type of processing will need a separate licence. The rates have also changed. The base cost of a hemp license is now $400, with an additional $250 per growing or processing location. The previous $250 processor license fee has been removed, but a 5% surcharge now applies to upgrades to MDA’s technology systems.
All authorized representatives listed on an application must pass a background check before being licensed. In addition, each lot of hemp must undergo THC testing before harvest, and each official sample collected by the MDA costs $100.
These issues “pose serious risks to public safety, market integrity, and the tax revenue framework that supports Colorado’s regulated cannabis industry.”
By Christopher Osher, ProPublica and Evan Wyloge, The Denver Gazette
This story was originally published by ProPublica.
Colorado regulators announced Monday that they plan to crack down on companies that sell cheaper, potentially dangerous, illegal hemp products as marijuana.
The state’s Division of Marijuana Enforcement said it had identified “compliance issues” that threaten to dismantle the marijuana industry in the nation’s first legal retail market.
These problems “pose serious risks to public safety, market integrity and the tax revenue framework that supports Colorado’s regulated cannabis industry,” the agency said in an industry newsletter.
An investigation by the Denver Gazette and ProPublica in January reported that despite Colorado being one of the first states to ban the sale of intoxicating hemp products, the legislature and regulators. he failed adopting many of the rules that other states have used to keep hemp products off the medical marijuana shelves.
Creating evaporative and edible liquid distillate from hemp is much cheaper than using marijuana, giving companies a competitive advantage.
But regulators say they are concerned that manufacturers are relying on toxic and dangerous chemicals to convert the non-toxic CBD compound that is predominant in hemp into THC, the psychoactive compound that makes people feel high. Regulators have banned this chemical synthesis, saying they fear chemical residues could remain in the finished product, putting consumers at risk.
Colorado manufacturers have taken advantage of loopholes in the state’s testing and enforcement system to continue using hemp to make products marketed as marijuana, even though doing so is against state law, according to regulatory studies, previous agency bulletins and testimony and lab results contained in several lawsuits.
In 2024, state investigators found that a popular brand of marijuana sold at dispensaries was not only derived from hemp, but also contaminated with methylene chloride, the chemical often used to convert CBD from hemp into THC. Marijuana is banned by Colorado regulators and banned for most uses by the US Environmental Protection Agency because it can cause liver and lung cancer and damage the nervous, immune and reproductive systems.
Ware House, the company that manufactured these vaporizers, relinquished its marijuana license in response to the investigation. Ware Hause’s owner, Thanh Hau, and the company’s lawyer declined to comment.
Congress passed a law last November that bans nearly all hemp products nationwide starting this fall, but it’s unclear how the government will enforce the ban, and hemp growers are reeling.
In December, President Donald Trump issued an executive order telling his aides to work with Congress to develop rules that could allow certain hemp products.
The Colorado Division of Marijuana Enforcement made the announcement Monday newsletter agency officials stated that they “identified and investigated evidence” that marijuana companies are using illegal practices and prohibited methods to manufacture products, instead of relying on marijuana, which is supposed to be monitored for safety.
The Colorado Hemp Association and the Colorado Hemp Education Association did not immediately respond to requests for comment.
Beyond safety concerns, the bulletin also noted that some marijuana manufacturers and growers are avoiding marijuana tax obligations through “a pattern of non-compliance” in sales operations they report to the state’s “seed-to-sale” tracking system, which tracks marijuana from the initial planting to the sale of flower, vapes and other products at dispensaries.
Companies misrepresent marijuana sales at nominal prices, in some cases as low as $1 per pound for unprocessed marijuana material, the newsletter said. Those products typically fetch more than $600 per pound on the market, depending on the category of marijuana, according to industry experts.
That fraudulent reporting has stolen millions of dollars in marijuana taxes from state and local governments, industry experts say, though no official estimate is available.
The agency said it will follow emergency rules to address these issues. The bulletin emphasized that suspicious and abnormal transactions and inventories detected by the state will prompt investigations. Companies caught using hemp or other illegal material passed off as marijuana face “immediate product embargo, license suspension or revocation, significant fines and law enforcement,” regulators warned.
The Denver Gazette and ProPublica have tried to track the anomalous transactions, but the Division of Marijuana Enforcement’s sales transaction records, even those that do not identify the companies, are not public.
Marijuana industry representatives met with the division’s regulators late last month to push for a more aggressive response to the agency’s hemp replacement, even though it could affect some companies in the industry. The representatives argued that bad actors are unfairly driving down prices and shifting the tax burden to manufacturers and growers who are trying to comply with the rules. The newsletter was released a couple of weeks after that meeting.
“The division is also considering additional changes to its testing and screening protocols” to detect illegal products and prohibited methods, and may require additional laboratory tests “if needed for products throughout the supply chain,” the agency’s bulletin said.
This article was produced in partnership with ProPublica’s Local Reporting Network Denver Magazine. Sign up for Submissions to receive stories in your inbox every week.
Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.
The medicinal cannabis sector is struggling to take root, and another specialist processing plant is set to close. But with current regulations and a new collective industry in mind, New Zealanders are promising to reduce their reliance on imported medicinals.
There was great excitement when medicinal cannabis was legalized and then regulated in 2020, with the hope of growing the domestic sector and serving patients here and abroad. However, since then, several companies have closed their doors, including Greenfern Industries, Cannasouth and, most recently, Helius Therapeutics.
The latter plans to close the East Tāmaki plant, affecting 65 workers. It is one of the few medicinal cannabis factories in the entire nation that has a specialized processing certificate called “Good Manufacturing Practice” (GMP).
Medical Cannabis Council executive director Sally King said that under current rules, most growers did not have such certification, and could only sell raw ingredients, not processed products such as more profitable cannabis capsules.